5,414 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Reddit Inc. (RDDT) Advances But Underperforms Market: Key Facts https://www.zacks.com/stock/news/2310339/reddit-inc-rddt-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2310339 Jul 26, 2024 - Reddit Inc. (RDDT) closed the most recent trading day at $62.36, moving +0.48% from the previous trading session.
Vistra Corp. (VST) Advances But Underperforms Market: Key Facts https://www.zacks.com/stock/news/2310342/vistra-corp-vst-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2310342 Jul 26, 2024 - Vistra Corp. (VST) closed the most recent trading day at $71.12, moving +1.05% from the previous trading session.
SoFi Technologies, Inc. (SOFI) Rises Higher Than Market: Key Facts https://www.zacks.com/stock/news/2310344/sofi-technologies-inc-sofi-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2310344 Jul 26, 2024 - SoFi Technologies, Inc. (SOFI) closed the most recent trading day at $7.41, moving +1.93% from the previous trading session.
Building the middle class may be a ‘defining goal’ under a Harris presidency — how that may shape a key tax credit https://www.cnbc.com/2024/07/26/what-a-harris-presidency-could-mean-for-her-lift-act-proposal.html Jul 26, 2024 - Vice President Kamala Harris, the front-runner for the Democratic presidential nomination, has positioned herself as a champion for the middle class.
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales https://www.zacks.com/stock/news/2310311/utah-medical-utmd-q2-eps-falls-y-y-on-lower-key-customer-sales?cid=CS-ZC-FT-analyst_blog|earnings_article-2310311 Jul 26, 2024 - Utah Medical (UTMD) reports a 19.2% revenue decline in 2Q24, with EPS down 15.3% due to lower sales to major customers. Despite this, profit margins remained stable.
Compared to Estimates, Premier Financial (PFC) Q2 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2310085/compared-to-estimates-premier-financial-pfc-q2-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2310085 Jul 26, 2024 - The headline numbers for Premier Financial (PFC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
WesBanco (WSBC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2310083/wesbanco-wsbc-q2-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2310083 Jul 26, 2024 - While the top- and bottom-line numbers for WesBanco (WSBC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Franklin Resources (BEN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2310084/franklin-resources-ben-q3-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2310084 Jul 26, 2024 - While the top- and bottom-line numbers for Franklin Resources (BEN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Woodward (WWD) Set to Post Q3 Earnings: Key Factors to Note https://www.zacks.com/stock/news/2310125/woodward-wwd-set-to-post-q3-earnings-key-factors-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310125 Jul 26, 2024 - Woodward's (WWD) Q3 earnings are expected to have gained from steady momentum across the Aerospace and Industrial business segments.
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs https://seekingalpha.com/article/4707032-teva-q2-earnings-preview-key-developments-biosimilars-pipeline-drugs?source=feed_tag_israel Jul 26, 2024 - Teva Pharmaceutical stock is up 69% since December. The company is set for Q2 earnings on July 31. See why I maintain my Hold rating on TEVA stock.
<<<Page 105>